why choose us

First received: February 22, 2023

Clinical Trial: Oxytocin Effects on Bone Metabolism in Children With Autism Spectrum Disorder

Study Status: Completed

Recruit Status: RECRUITING

Condition: Autism Spectrum Disorder

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled Study of Intranasal Oxytocin for Bone Health in Children With Autism Spectrum Disorder

Brief Summary: This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin on bone health in children with autism spectrum disorder, ages 6-18 years old.Subjects will be randomized to receive intranasal oxytocin or placebo (30 IU, 2 times daily) for 12 months in the double-blind phase, followed by a 6-month open label phase during which all study subjects will receive intranasal oxytocin (30 IU, 2 times daily).Study visits include screening to determine eligibility, followed by study visits…

Read more